IMUNITI A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Diseas

  • Selby, Lisbeth (PI)
  • De Villiers, Willem (Former PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/16/12 → 10/30/16